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AbstractWe utilised postmortem brain tissue to quantify
sections of left and right orbitofrontal cortex (area 11)
from nine schizophrenic and eight control patients from
the Charing Cross Prospective Schizophrenia Study im-
munostained for the presence of the kainate receptor
(GluR5/6/7). The numerical density of neurons immu-
nopositive for kainate receptor was measured. Other
sections from the same blocks were stained with cresyl
violet to determine the total neuronal numerical density.
All measurements were made blind: diagnoses were only
revealed by a third party after measurements were com-
pleted. There was a signiﬁcant reduction (21%) in
numerical density of kainate receptor-positive neurons in
both cortices in the schizophrenic group (488 cells/mm2)
compared to that in the control group (618 cells/mm2)
(P=0.033). Nissl-stained tissue showed no signiﬁcant
diﬀerence in total neuronal numerical density between
control and schizophrenic groups. These observations
suggest that there are actually fewer kainate receptor-
positive neurons in schizophrenic orbitofrontal cortex.
There was no correlation of reduced kainate receptor-
positive cell number with age at death, postmortem
interval, or other possibly confounding neuropathology.
Our results support the concept of there being reduced
glutamatergic activity in frontal cortex in schizophrenia.
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Introduction
Since the observation that the cerebrospinal ﬂuid of
schizophrenics contained less glutamate than that of
controls (Kim et al. 1980), there has been increasing
evidence that glutamate receptors play a role in schizo-
phrenia (Deutsch et al. 1988; Hirsch et al. 1997). Phen-
cyclidine (PCP) and amantidine, both glutamate
N-methyl-D-aspartate (NMDA) receptor antagonists, can
elicit a psychotic state resembling schizophrenia, which
includes negative as well as positive symptoms (Luby et al.
1959; Zukin and Zukin 1979; Lodge et al. 1987; Javitt and
Zukin 1991; Meltzer 1991; Kornhuber et al. 1993).
The kainate subtype of glutamate receptor has been
shown to colocalise with other subtypes in prefrontal
cortical neurons in monkeys (Vickers et al. 1993).
Although increases in glutamate receptor binding
(including kainate receptors) have been reported in
postmortem samples from the prefrontal cortex of
schizophrenics (Nishikawa et al. 1983; Toru et al. 1988;
Deakin et al. 1989), kainate receptors are down-regu-
lated in the neocortex and hippocampus in schizophre-
nia (Kerwin et al. 1990; Harrison et al. 1991; Porter et al.
1997; Sokolov 1998). It has also been shown that in
schizophrenics glutamatergic cortical pyramidal neurons
have fewer than normal dendritic spines, on which glu-
tamate receptors are concentrated (Garey et al. 1998;
Glantz and Lewis 2000).
The prefrontal cortex is hypoactive in schizophrenia
(Rubin et al. 1994). Its regional cerebral blood ﬂow is
decreased in schizophrenics performing various neuro-
psychological tests (Weinberger et al. 1986; Satoh et al.
1993). In particular, the orbitofrontal cortex (area 11 of
Brodmann 2005) has been implicated with aﬀective
behaviour and integration of emotional responses in
monkey and man (Lewin 1960; Gray 1981; Grafman
et al. 1986).
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We therefore decided to compare the numerical
density of neurons stained by an immunocytochemical
method for kainate receptor in the orbitofrontal cortex
of a series of schizophrenic and control postmortem
specimens. We tested the hypothesis that kainate
receptor-positive cells are reduced in schizophrenia, and
examined whether this was independent of total cell
count, determined from Nissl-stained sections, and other
important variables such as age and postmortem interval
(PMI).
Methods
Specimens and ﬁxation
Samples from the orbitofrontal cortex (area 11) of nine
schizophrenic (ﬁve males, four females) and eight con-
trol patients (three males, ﬁve females) were used
(Tables 1, 2) from the Charing Cross Prospective
Schizophrenia Study, as approved by the Charing Cross
Hospital Ethics Committee. The average age of the
controls was 64 years (range 27–81), and of the schizo-
phrenics was 75 (range 46–86). The mean PMI (the delay
from death to ﬁxation of tissue) was 28 h for the con-
trols and 14 h for the schizophrenics. The diagnosis of
schizophrenia was made using DSM-IIIR criteria, but
was only revealed to the experimenters by a third party
after the completion of all measurements. Gross path-
ological abnormalities were excluded by visual inspec-
tion of the whole brain and coronal slices at the time of
autopsy. Particular attention was paid to the substantia
nigra and the caudate nucleus (for Parkinson and
Huntington disease, respectively).
After removal from the skull, each brain was dis-
sected according to a standardised protocol. For the
present study, blocks from the left and right area 11 were
immersed in 4% buﬀered paraformaldehyde for ﬁxation
before being embedded in paraﬃn wax, sectioned at
10 lm, and mounted on glass slides coated with chrome-
alum gelatin.
Kainate receptor immunostaining
Four sections from each block were immunostained with
a mouse monoclonal antibody recognising the kainate
receptor subunit GluR5/6/7 in mouse, monkey and man
(Chemicon) previously described as labelling speciﬁc
neurons in primate neocortex (Huntley et al. 1993).
After dewaxing, the slides were soaked in 0.3% hydro-
gen peroxide in phosphate-buﬀered saline for 30 min to
block any endogenous peroxidase reactions, and
microwaved in citrate buﬀer (pH 6) for 5 min to enhance
the presentation of the antigen (Newman and Gentle-
man 1997). The slides were then immersed in a block-
ing solution (Vector Laboratories SP-2001) to block
endogenous avidin and biotin, before incubating over-
night in the kainate receptor antibody diluted 1:200. A
standard ABC (Vectastain) routine was then used, and
the staining visualised using a metal-enhanced diam-
inobenzidine substrate in stabilised peroxide buﬀer
solution (Pierce Chemical), with subsequent treatment in
0.01% osmium tetroxide solution. The sections were
dehydrated and covered, and then quantiﬁed. Kainate
receptor-positive cells in a column from the pia to the
white matter were counted at ·200 independently by two
observers using a microscope with a calibrated 10·10
graticule. The cells that were counted were all judged to
be neurons using criteria of their relatively large size,
their shape, staining density and high cytoplasm to
nucleus ratio. The occasional immunopositive glial cells
were not counted (see Results). For each brain, the mean
value of the two observers’ counts of cells per mm2 was
calculated. Diﬀerences between the schizophrenic and
control brains were tested for signiﬁcance by using the
non-parametric Mann–Whitney test. Two-tailed statis-
tics were used. The Mann–Whitney test was chosen
because the left-sided total cell counts were skewed in
both diagnostic groups, as were the right-sided values in
the schizophrenic group, and the PMIs. Only neurons
that were sectioned through their nucleus were counted,
but we elected not to use formal stereological method-
ology. Although this may have reduced the absolute
Table 1 Details of the control brains used in this study
Case number Sex Age PMI Kainate L Kainate R Nissl L Nissl R Cause of death Plaques Tangles
16 F 67 1 443 477 1,027 1,077 PE
27 F 79 29 688 631 1,265 1,226 Peritonitis
28 M 57 22 487 546 935 932 PE
29 M 54 29 637 578 908 993 Renal failure
30 F 27 27 572 536 896 715 Hepatic failure
31 F 81 80 784 731 881 1,341 GI haemorrhage
35 M 67 18 518 480 978 1,054 Septicaemia
89 F 79 16 874 903 1,171 1,178 MI ++ 
Mean 64 28 625 610 1,008 1,065
Mean L + R 618 1,036
SD 142.6 165.6
Each column of results refers to the numerical density of neurons per mm2 in kainate receptor immunostained or Nissl-stained sections
from the left (L) or right (R) cortex. The two bottom lines refer to the means and standard deviations of results from both sides
PMI postmortem interval in hours (from death to ﬁxation of tissue), PE pulmonary embolism, GI gastrointestinal, MI myocardial
infarction
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reliability of our results, we consider that the technique
described above gives an acceptable degree of conﬁdence
in comparing individual cases across the cohorts.
Nissl staining
Of the remaining sections from each block, two were
stained with cresyl violet for Nissl substance to deter-
mine total cell numerical density. Cells were counted in
these Nissl-stained sections using a SeeScan image
analysis system. Two columns from the pia to the white
matter were chosen and all cells with a diameter greater
than 8 lm counted. It was assumed that smaller cells
would be mainly, if not all, glia. Again, the results were
expressed as cells per mm2.
Two other sections were stained for glial ﬁbrillary
acidic protein (GFAP) to identify astrocytes.
Seven of the schizophrenic brains and one control
were subjected to a modiﬁed CERAD examination
(Mirra et al. 1991). Blocks from frontal, temporal,
parietal, occipital and cingulate cortex were stained with
IE8 antibody for plaques and AT8 for tangles (Tables 1,
2). Material was not available for this from the other
cases.
Results
Histology
Cells labelled for kainate receptor were visible in all
cortical layers. The most clearly labelled cells were
large and small pyramidal neurons, especially in layers
III and V. Their soma had a large volume of light
cytoplasm compared with the nuclear size, and apical
and basal dendrites were easily visible. Medium to
small non-pyramidal cells, again with large volumes of
light cytoplasm, were also stained, mainly in layers II
and IV. Almost all immunopostive cells were judged to
be neurons, in that none were very small, and they
had the morphological characteristics of neurons (see
above). A few kainate receptor-positive cells were
identiﬁed as astrocytes by their typical morphology
(small soma with multiple, ﬁbrous ramiﬁcations).
Bundles of axons were also labelled, both in the white
matter and fanning out into the deep layers of grey
matter, especially near the apex of gyri (Fig. 1).
Results from Nissl-stained sections
Results (Tables 1, 2 and Fig. 2) from Nissl-stained sec-
tions showed that the total numerical density of neurons
in the left and right cortices of the schizophrenic group
(1,160 and 1,111 cells/mm2) was not signiﬁcantly dif-
ferent from that in the left and right cortices of the
control group (1,008 and 1,065), but approached sig-
niﬁcance for the left cortex (P=0.063, t=2.006). Mean
values were therefore calculated for both sides (1,135
and 1,036), again revealing no signiﬁcant diﬀerence
(Table 1). However, although not reaching signiﬁcance,
in each case (left cortices, right cortices and both cor-
tices combined) there was a consistent, slightly higher
numerical density of neurons in the schizophrenic brains
of 13% between left cortices, 4% between right cortices,
and 9% overall between schizophrenics and controls.
Kainate receptor-positive cells
Results from kainate receptor-immunostained tissue
revealed no signiﬁcant diﬀerence in the number of
immunopositive neurons between left and right sides of
control or schizophrenic brains. However, there were
signiﬁcantly fewer kainate receptor-positive neurons
in the schizophrenics than the controls, when the left or-
bitofrontal cortex of the schizophrenic group (483 cells/
mm2) was compared to the left cortex of the control
group (625 cells/mm2), i.e. a 23% reduction (P=0.033).
A comparison of the right orbitofrontal cortex of the
schizophrenic group (494 cells/mm2) with that of the
right cortex of the control group (610 cells/mm2) showed
a non-signiﬁcant (19%) reduction (P= 0.060). When
Table 2 Details of the schizophrenic brains used in this study
Case number Sex Age PMI Kainate L Kainate R Nissl L Nissl R Cause of death Plaques Tangles
12 M 65 72 457 443 1,131 1,026 Bronchopneumonia  +
21 M 82 5 587 585 991 892 Bronchopneumonia
39 M 80 4 429 462 1,317 1,349
84 F 46 23 470 523 1,056 958 Hanging  
85 F 82 8 431 438 1,404 1,435 Bronchopneumonia  
86 M 77 3 445 474 1,116 1,166 Bronchopneumonia +++ ++
87 M 79 5 531 491 1,232 1,213 Ca bronchus + 
88 F 75 3 481 491 885 781 Ca bladder + 
90 F 86 5 515 539 1,309 1,175 Ca gall bladder ++ +
Mean 75 14 483 494 1,160 1,111
Mean L + R 488 1,135
SD 49.1 189
Layout and conventions as for Table 1
Ca carcinoma
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both the left and right cortex of the schizophrenic group
were combined and compared to those in the control
brains, the lower numerical density of stained neurons in
the schizophrenic group was highly signiﬁcant (488
compared with 618; 21% reduction; P=0.001) (Table 1).
Of the nine schizophrenic brains, material was
available from seven to study for the presence of plaques
and tangles indicative of possible Alzheimer disease.
Only one (number 86) showed signs of moderate to
heavy involvement, and one other (number 90) light to
moderate.
Discussion
In human orbitofrontal cortex, we found kainate
receptor-positive neurons in all cortical layers in both
control and schizophrenic tissue. Pyramidal and non-
pyramidal cells were labelled, and staining was seen not
only in somata and dendrites, but also in axons in the
white and grey matter (Vickers et al. 1995). The fact that
GluR staining is not conﬁned to the cortical neuropil
(where it stains asymmetrical postsynaptic densities), but
marks neuronal cell bodies, is revealed by our own and
others’ light and electron microscopic studies in rat
(Petralia and Wenthold 1992; Petralia et al. 1994; Ong
and Gorey 1996), monkey (Huntley et al. 1993) and man
(Ong and Garey 1996). In our present material, some
cells with typical features of astrocytes were stained for
kainate receptor. We compared the sections stained for
GFAP (see Methods) to conﬁrm this diagnosis. There
was no suggestion in any of the sections examined of
actual gliosis. Glia have been reported to stain for kai-
nate in human cortex from epileptic and other patho-
logical cases (DeFelipe et al. 1994; Vickers et al. 1995).
Although we did not use formal stereological meth-
odology for quantiﬁcation, as described in Methods, we
believe that our counting technique gave an acceptable
level of reliability. We found a signiﬁcant decrease of
21% in the numerical density of neurons stained for
kainate receptor in schizophrenic cortex compared to
Fig. 1 Micrograph of a section
from orbitofrontal cortex of a
schizophrenic, labelled for
kainate receptor. Note the
staining of pyramidal and non-
pyramidal cell bodies, and of
neuropil proﬁles, especially
dendrites
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Fig. 2 Histograms to show the numerical density of neurons
(showing mean values±SD) stained for kainate receptor and Nissl
substance, respectively in control and schizophrenic (sz) brains.
There is a signiﬁcant (P=0.001) reduction in kainate receptor-
positive neuronal density, and a consistent but non-signiﬁcant
increase in total neuronal density, in schizophrenic cortex
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the control group. In contrast, the counts of Nissl-
stained neurons were not signiﬁcantly diﬀerent between
controls and schizophrenics, although there was a con-
sistent trend toward a small increase in neuronal
numerical density in the schizophrenic cortex. Previous
literature suggests a decrease in the thickness of the
cortex in schizophrenics compared to normal controls
(Selemon et al. 1995). This could cause an increase in the
numerical density of neurons, without a decrease in their
total number in the cortex. As the total numerical den-
sity of neurons in the cortex thus does not change
signiﬁcantly, but may even be slightly increased, the
ﬁnding of fewer neurons per unit area expressing the
kainate receptor in schizophrenics suggests a real loss of
neurons labelled for kainate receptor. It is of interest
that Benes et al. (2001) described a decrease of some
30% in the number of apical dendrites immunoreactive
for GluR5/6/7 on pyramidal neurons in the stratum
radiatum of the hippocampus in schizophrenic brains.
Our ﬁndings are, however, in contrast to the work
showing an increase in kainate binding in frontal cortex
of schizophrenics (Nishikawa et al. 1983; Deakin et al.
1989). However, this previous work was done with brain
homogenates and is not directly comparable to the
quantiﬁcation of receptor-positive neurons in the pres-
ent work.
There are several confounding factors that must be
considered in our study. The ﬁrst is that of age. The
mean age of the schizophrenics was higher than that of
the controls (75 years compared to 64). Figure 3 illus-
trates scatter plots of all the results of this study with
linear regression lines added. There is a slight tendency
for increased neuronal density with age, both for Nissl
results (total neurons), as described earlier (Leuba and
Garey 1987), and for kainate receptor-positive cells.
However, this trend cannot explain the low neuronal
density in the schizophrenics. Indeed, if the control aged
27 (outside the age range of the schizophrenics) is
excluded, the reduction in the density of kainate recep-
tor-positive cells is slightly greater (22%).
None of our schizophrenic patients had clinical
Alzheimer disease, as determined from their hospital
notes, and no sign of it macroscopically at autopsy.
Modiﬁed CERAD (Mirra et al. 1991) staining for
plaques and tangles revealed possible (subclinical)
Alzheimer pathology in two brains. Neither showed
particularly low neuronal counts, either for total cells
or kainate receptor. If Alzheimer disease had existed in
any of our controls, it would be expected to act against
the hypothesis that loss of kainate receptor-positive
cells in schizophrenia might be induced by this (or
other) pathology. We interpret these results as sugges-
tive of Alzheimer disease not being a confounding
factor in our study. Interestingly, case 21 was reported
clinically as having non-Alzheimer type dementia, and
had the highest number of kainate receptor-positive
neurons in this series.
One of our controls (case 16) had been diagnosed
with an atypical psychosis 2 years before death. As there
was no history of schizophrenia as such, we maintained
this case in the control group. It is worth noting that if
she had been excluded, the mean count for kainate
receptor-positive neurons in the controls would have
been even higher (640/mm2, rather than 618), without a
signiﬁcant change in total neuronal density.
It is possible that treatment of our schizophrenic
patients with neuroleptics could inﬂuence receptors.
They may have variable, and even toxic eﬀects in ani-
mals (Sommer and Quandt 1970; Eastwood et al. 1994,
1996; Healy and Meador-Woodruﬀ 1997). However,
Benes et al. (1985) found no correlation between neu-
roleptic treatment and total neuronal density in a com-
parison of schizophrenics and controls, and others have
suggested that such therapy probably does not aﬀect
glutamate receptors (Eastwood et al. 1994; Oretti et al.
1994). Sokolov (1998) demonstrated that levels of
glutamate receptor mRNA in schizophrenics receiving
neuroleptics up to death did not diﬀer from those
in controls, but actually declined after cessation of
neuroleptic therapy.
The eﬀect of an altered social environment must also
be considered. The schizophrenics had spent long peri-
ods in institutions, compared with controls from com-
paratively rich social environments. The eﬀects of social
deprivation in humans are unknown, and new material is
now being collected from institutionalised non-schizo-
phrenics and younger, non-chronic schizophrenics.
Postmortem delay could result in tissue damage, and
this might lead to loss of immunoreactivity. However, in
our cases the mean PMI was twice as long for the con-
trol cases, thus acting against that hypothesis. Further-
more, we found no consistent relationship between PMI
and kainate receptor staining. The shortest PMI was in
case 16, where the count of immunopositive cells was
below average. The case with the longest delay (number
31) had a high count.
The present ﬁnding of a decreased numerical density
of neurons labelled for kainate receptor in the orbito-
frontal cortex of schizophrenic patients is consistent
with glutamate receptor hypofunction, or dysfunction.
Down-regulation of glutamate receptor activity has been
widely implicated in schizophrenia (Deutsch et al. 1988;
Kerwin et al. 1990; Harrison et al. 1991; Sherman et al.
1991; Squires and Saederup 1991; Lieberman and
Koreen 1993; Humphries et al. 1996; Porter et al. 1997;
Sokolov 1998). A combined dysfunction of dopamine
and glutamate receptors has also been proposed (Olney
and Farber 1995). Glutamate receptors are present on
the dendrites and spines of cortical neurons, including
pyramidal cells (Petralia et al. 1994; He et al. 1996; Ong
and Garey 1996) which are heavily stained for kainate
receptor in the present study. Since pyramidal neurons
are intercortical association cells, it is possible that
communication between neocortical areas may be dis-
rupted as a result of loss of glutamate receptors. Pre-
frontal cortex is strongly connected to other association
cortex and the limbic system. Lesions of the frontal lobe
aﬀect higher cognitive function (Gold et al. 1992). Thus,
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down-regulation of kainate receptor activity or connec-
tivity in frontal cortex could disturb complex integrative
functions, leading to changes in higher cognitive activity
such as seen in schizophrenia.
Electron microscopy of schizophrenic cortex has
shown abnormal excitatory synapses with vesicles that
clump away from unusually short postsynaptic densities
where glutamate receptor is situated (Ong and Garey
1993). Excessive pruning of prefrontal synapses, perhaps
involving excitatory glutamatergic input to pyramidal
neurons, is a possible aetiological factor in schizophre-
nia (Keshavan et al. 1994). Observations of reduced
numbers of pyramidal dendritic spines in schizophrenia
(Garey et al. 1998; Glantz and Lewis 2000), may be
related to the concept of disturbed elimination of con-
nections in the neuropil, including that of exuberant
connections that are a normal part of development
(Innocenti and Price 2005).
In addition, excitatory glutamatergic activity at syn-
apses, including at kainate receptors, is linked to the
normal development of neurons (Henley 1994), and their
connections (Shatz 1990). NMDA receptors are also
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Fig. 3 Linear regression curves
to test the eﬀect of age on
neuronal density in control
(a) vand schizophrenic (b)
brains. Nissl results for each
side of each brain are indicated
by triangles and kainate results
by squares. In some cases the
values overlap. There is a slight
tendency for increased neuronal
density with age, more marked
for the Nissl results
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involved in the detection of coincidental pre- and post-
synaptic activity at excitatory synapses, linked to in-
crease in synaptic eﬃcacy, memory formation and
learning (Morris et al. 1986; Bliss and Collingridge
1993). Disturbance of any of these factors could be of
importance in the pathogenesis of schizophrenia. It
remains, however, to determine whether the decrease in
kainate receptors is a cause or a consequence of neuro-
nal pruning in schizophrenia.
The present results, taken in conjunction with evi-
dence of reduced GABAergic neuronal activity as judged
by gene expression deﬁcits in neurons positive for GABA
enzymes or calcium-binding proteins without actual loss
of neurons themselves (Akbarian et al. 1995, Leclercq
et al. 1996, Leuba et al. 1997, Reynolds and Beasley 2001,
Hashimoto et al. 2003), provide support for the concept
that schizophrenia may be a disease of microcircuitry in
the neuropil rather than of neuronal number (Selemon
and Goldman-Rakic 1999). Further, our observation
that the numerical density of microglia is signiﬁcantly
higher in schizophrenia than in controls, may also point
to possible precocious alterations in neuropil architec-
ture in schizophrenia (Radewicz et al. 2000).
There have been suggestions that schizophrenia may
be related to abnormal hemispheric asymmetry or later-
alisation (Crow et al. 1989). However, we ﬁnd no evidence
of signiﬁcant hemispheric diﬀerences in the phenomena
that we describe here, although we examined both hemi-
spheres, and the same applies to our previous results
(Radewicz et al. 2000). It should also be emphasised that
the pathological changes identiﬁed in schizophrenia
to date are not restricted to a speciﬁc area of cortex,
although most have related to hippocampus or associa-
tion neocortex. For example, we have demonstrated
changes, described above, in frontal, temporal and cin-
gulate cortex (Garey et al. 1998; Radewicz et al. 2000).
It would now be of interest to follow up the present
studies by quantifying the density of kainate receptor
labelling in the neuropil (essentially dendritic and axonal
marking) in controls and schizophrenics, especially as
we have noted decreased GABAergic labelling in
schizophrenic neuropil without decreased numerical
density of somata (Leuba et al. 1997).
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